Bacillus cereus

Matrix Suitability
Culture Media

bioMérieux BACARA® Agar

Method Description

Bacillus cereus Suitability Testing confirms that the method can effectively detect and recover B. cereus in a specific sample matrix. The assessment includes analysis of a fortified sample (matrix spike) and a laboratory control sample (LCS) prepared in a contaminant-free matrix. Recovery from the sample is compared to the LCS to evaluate matrix effects and ensure reliable detection. The Method utilizes selective and differential media to isolate B. cereus based on characteristic colony morphology and selective and differential characteristics.

Analyte List

4
analytes
Analyte NameLODLOQLCL
Bacillus Cereus (Laboratory Control Sample)1.000 CFU/g1.000 CFU/gN/A
Bacillus Cereus (Matrix Spike)1.000 CFU/g1.000 CFU/gN/A
Bacillus Cereus (Product Sample)1.000 CFU/g1.000 CFU/gN/A
Bacillus Cereus (Method Suitability - Relative Recovery)N/AN/AN/A

Technical Data Sheet

Test Name (LIMS/CoA)
Suitability - Bacillus cereus - Plate - 50 g
Method Name
Enumeration of Bacillus cereus
Method Code
ANA-TM-087
Platform Type
Culture Media
Platform Details
bioMérieux BACARA® Agar
Result Type
Suitability - Recovery
Reportable Unit
CFU/g · % relative r
Reportable Range
Acceptance: 50 – 200% relative recovery
Method References
USP <61>
Acceptable Matrices
Matrix-specific suitability evaluation required. Please inquire with the laboratory regarding your specific product matrix prior to submission.
*Prices and offerings are subject to change without notice.

Additional information

Product-specific suitability per USP <2021> (suitability of the counting method in the presence of the product). Three preparations are analysed side by side: the Product Sample as received, a Matrix Spike (the product inoculated with a low, known level of the target organism, not more than 100 CFU) and a Laboratory Control Sample (the same inoculum in diluent, without product). Relative Recovery (%) = Matrix Spike count ÷ Laboratory Control Sample count, after subtracting any background in the Product Sample. The reportable range 50 – 200% is the USP acceptance criterion (recovery within a factor of two): a result inside the range shows the product neither inhibits nor enhances the method, and routine USP-referenced testing of that product can proceed. Outside the range the method is modified (neutralisers, further dilution or membrane filtration) and the suitability is repeated.

Bacillus cereus
bioMérieux BACARA® Agar
qPCR
Test Code
STBCP
Status
Active
TaT
5–10 Business Days
Performing Lab
Cambium Analytica - In-House
Sample Needed
50 g
References
USP
Category
Microbiology
Subcategory
Microbial Assay Suitability
Industries Available
Dietary Supplements
Food

See what Cambium analytica can do for your team

contact us

complete this form to connect with a cambium analytica team member